EVERSANA Sponsors The Medicaid and Government Pricing Congress

Join the Live Virtual Medicaid and Government Pricing Congress. Stay Current with Legislative and Regulatory Actions that Affect Drug Pricing and Price Reporting.

Meet with EVERSANA’s Government Pricing experts to discuss the upcoming regulatory changes impacting government pricing. Michael Kurland, Vice President, Revenue Management and Compliance Solutions​ moderates a panel live.

Panel: How to Manage Challenging Reporting Issues with Calculation​
June 9th at 1:15 EST

Panelists Include:
Mike Kurland​, Vice President, Revenue Management and Compliance Solutions,​ EVERSANA
Patty Burke​, Manager, Government Pricing Analytics, Johnson & Johnson​
Jill Farkas​, Director, Government Pricing, Amgen​

Register for the panel here.

Schedule a meeting to speak with one of our experts.

 


Our experts are tracking the latest changes. Read their articles online:

News Alert: MCIT Program Delayed Until December
Gross-To-Net: Challenges and Best Practices
Drug Pricing And Drug Price Reporting Regulatory Update
Webinar: Drug Pricing and Reporting Regulatory Updates Part 1
Webinar: Drug Pricing and Reporting Regulatory Updates Part 2